Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
life sciences
national blog main
eli lilly
national top stories
abbvie
allergan
amgen
avapritinib
bempedoic acid
biohaven
blueprint medicines
boston
boston blog main
boston top stories
cgpr
cholesterol
corticosteroids
cstone pharmaceuticals
deals
detroit
detroit blog main
detroit top stories
esperion therapeutics
europe blog main
european medicines agency
ezetimibe
fisogatinib
flatiron health
fluoroquinolones
genentech
hepatocellular carcinoma
investing
jeff albers
medullary thyroid cancer
merck
migraine
national
What
fda
3
×
medicines
wins
3
×
approved
drug
nod
pill
regulatory
adults
allergan
approval
blueprint
cancer
candidate
cholesterol
class
combo
currently
esperion
esperion’s
levels
lowering
marketing
migraine
monday
muscle
new
pact
pairs
ret
review
roche
second
single
team
therapeutics
treat
treatment
ubrelvy
ubrogepant
Language
unset
Current search:
wins
×
fda
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
